About Fulgent Genetics
Fulgent Genetics is a company based in Temple City (United States) founded in 2011 was acquired by Fulgent Pharma in November 2022.. Fulgent Genetics has raised $64.25 million across 5 funding rounds from investors including Fulgent Pharma. The company has 1,310 employees as of December 31, 2024. Fulgent Genetics has completed 4 acquisitions, including CSI Laboratories, Fulgent Pharma and Inform Diagnostics. Fulgent Genetics operates in a competitive market with competitors including Strand Life Sciences, Invitae, Genome Medical, Myriad Genetics and AnchorDx, among others.
- Headquarter Temple City, United States
- Employees 1310 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Fulgent Genetics, Inc.
-
Annual Revenue
$283.47 M-1.99as on Dec 31, 2024
-
Net Profit
$-42.71 M74.55as on Dec 31, 2024
-
EBITDA
$-48.99 M-12.52as on Dec 31, 2024
-
Total Equity Funding
$64.25 M (USD)
in 5 rounds
-
Latest Funding Round
$27.16 M (USD), Series A
May 24, 2016
- Investors
-
Employee Count
1310
as on Dec 31, 2024
-
Investments & Acquisitions
CSI Laboratories
& 3 more
-
Acquired by
Fulgent Pharma
(Nov 07, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Fulgent Genetics
Fulgent Genetics is a publicly listed company on the NASDAQ with ticker symbol FLGT in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Sales and Marketing
17 people
Leadership Team
12 people
Finance and Accounting
7 people
Software Development Team
5 people
Legal and Compliance
2 people
Operations Team
2 people
General Team
1 people
Human Resources and Administration
1 people
Unlock access to complete
Funding Insights of Fulgent Genetics
Fulgent Genetics has successfully raised a total of $64.25M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $27.16 million completed in May 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $27.2M
-
First Round
First Round
(16 Oct 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2016 | Amount | Series A - Fulgent Genetics | Valuation |
investors |
|
| May, 2016 | Amount | Series A - Fulgent Genetics | Valuation |
investors |
|
| Apr, 2016 | Amount | Series A - Fulgent Genetics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Fulgent Genetics
Fulgent Genetics has secured backing from 1 investor. Prominent investors backing the company include Fulgent Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drugs for cancer treatment are developed using nanoencapsulation technology.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Fulgent Genetics
Fulgent Genetics has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include CSI Laboratories, Fulgent Pharma and Inform Diagnostics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Standalone pathology lab services are offered in the United States.
|
2018 | ||||
|
Pathology testing services are offered by a standalone laboratory.
|
2011 | ||||
|
Drugs for cancer treatment are developed using nanoencapsulation technology.
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Fulgent Genetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Fulgent Genetics Comparisons
Competitors of Fulgent Genetics
Fulgent Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Strand Life Sciences, Invitae, Genome Medical, Myriad Genetics and AnchorDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Home-based genetic tests for detecting diseases are provided to individuals.
|
|
| domain | founded_year | HQ Location |
Genomic testing services are provided clinically and directly to consumers.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostics and personalized medicine for cancer are developed.
|
|
| domain | founded_year | HQ Location |
High-throughput gene sequencing platform is developed for clinical diagnostics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Fulgent Genetics
Frequently Asked Questions about Fulgent Genetics
When was Fulgent Genetics founded?
Fulgent Genetics was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Where is Fulgent Genetics located?
Fulgent Genetics is headquartered in Temple City, United States. It is registered at Temple City, California, United States.
Who is the current CEO of Fulgent Genetics?
Ming Hsieh is the current CEO of Fulgent Genetics.
Is Fulgent Genetics a funded company?
Fulgent Genetics is a funded company, having raised a total of $64.25M across 5 funding rounds to date. The company's 1st funding round was a Series A of $5.4M, raised on Oct 16, 2015.
How many employees does Fulgent Genetics have?
As of Dec 31, 2024, the latest employee count at Fulgent Genetics is 1,310.
What is the annual revenue of Fulgent Genetics?
Annual revenue of Fulgent Genetics is $283.47M as on Dec 31, 2024.
What does Fulgent Genetics do?
Fulgent Genetics was founded in 2011 and is headquartered in Temple City, United States. Genetic testing services are provided in the healthcare sector, focusing on carrier screening for cardiovascular diseases, epilepsy, and cancer. Next-generation sequencing technology is utilized for rare diseases, whole-genome sequencing, copy number variation analysis, and mitochondrial sequencing to support clinical diagnostics.
Who are the top competitors of Fulgent Genetics?
Fulgent Genetics's top competitors include Strand Life Sciences, Centogene and Myriad Genetics.
Is Fulgent Genetics publicly traded?
Yes, Fulgent Genetics is publicly traded on NASDAQ under the ticker symbol FLGT.
How many acquisitions has Fulgent Genetics made?
Fulgent Genetics has made 4 acquisitions, including CSI Laboratories, Fulgent Pharma, and Inform Diagnostics.
Who are Fulgent Genetics's investors?
Fulgent Genetics has 1 investor. Key investors include Fulgent Pharma.
What is Fulgent Genetics's ticker symbol?
The ticker symbol of Fulgent Genetics is FLGT on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.